Physician profile
Caroline Long
NPI 1225601750
$3,386.80
in general payments reported to CMS, 2019-2025
22 companies · $791 in 2025
The $791 reported for 2025 was more than what 79% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $27.30 · 2022: $740 · 2023: $964 · 2024: $864 · 2025: $791.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,508 · Education: $112.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,507.51 |
| Education | $112.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $669.20 | 2022-2025 | Wegovy, Ozempic, Rybelsus |
| Astellas Pharma US INC | $573.93 | 2023-2025 | Veozah, Myrbetriq |
| Sumitomo Pharma America, INC. | $514.05 | 2023-2025 | Gemtesa, Myfembree |
| Currax Pharmaceuticals LLC | $302.78 | 2021-2025 | Contrave |
| Pfizer INC. | $162.93 | 2022-2024 | |
| Lilly USA, LLC | $133.25 | 2023-2025 | Zepbound, Mounjaro |
| Urovant Sciences INC | $126.83 | 2022 | |
| Millicent US INC | $126.28 | 2024-2025 | Intrarosa, Femring, Femlyv |
| Exact Sciences Corporation | $125.48 | 2023-2025 | Cologuard Collection Kit |
| Mayne Pharma Commercial LLC | $123.64 | 2023-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $85.54 | 2021-2022 | |
| Hologic Sales and Service, LLC | $62.15 | 2022-2023 | Aptima |
| Amgen INC. | $59.48 | 2022-2025 | Prolia, Evenity |
| Agile Therapeutics, INC. | $53.91 | 2022-2024 | Twirla |
| Therapeuticsmd, INC. | $52.96 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $50.91 | 2022-2023 | |
| Organon LLC | $46.22 | 2022-2023 | Nexplanon |
| Bayer Healthcare Pharmaceuticals INC. | $38.85 | 2025 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $31.47 | 2022 | |
| Glaxosmithkline, LLC. | $17.60 | 2024 | Shingrix, Arexvy |
| Exeltis, USA INC. | $15.23 | 2022 | |
| Avion Pharmaceuticals | $14.11 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Caroline Long listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.